+91 124 421 3333

Dr. Sanjeev Chaudhary


He is a renowned interventional cardiologist with an experience of over 12 years. His last assignment was as senior interventional cardiologist at Paras hospitals Gurgaon where he worked for more than 5 years. He has a vast experience in performing coronary angioplasty and has performed over five thousand interventional procedures. He has a keen interest in clinical research and is principal investigator in many clinical research studies. He has contributed maximum number of cases all over India in multinational TAO study. He has a special interest in primary angioplasty ( angioplasty in acute heart attack) and coronary artery disease in diabetics.

Work Experience: 
  • Fellow of DNB, Cardiology Batra Hospital & Research Center, New Delhi 2002 – 2005
  • Consultant, Cardiology, Fortis Hospital Noida 2005 - 2006
  • Consultant, Cardiology, Escorts Heart Institute & Research Center, Delhi, 2006-2008
  • Senior Consultant, Cardiology, Paras Hospitals, Gurgaon, 2008-2013
  • Director, Cardiology, Fortis Memorial Research Institute,Gurgaon, 2013 - Present
Professional Memberships: 
  • Lifetime Member of Association of Physicians of India and
  • Member of Indian Society of Echocardiography
  • Life Membership Cardiology Society of India.
  • Fellow of European Society of Cardiology.
Speciality Interests: 
  • He has special interest in coronary angioplasty and coronary angiography
  • Coronary disease in the diabetics.
  • Complex coronary interventions.
Awards and Honours: 
  • Awarded double gold medalist in PGIMS, Rohtak
Research Experience : 
  • TAO STUDY Principal Investigator : Randomized double blind triple-dummy trial to compare the efficacy of otamixaban with Unfractionated Heparin & eptifibatide, in patients with Unstable angina Non ST segment Elevation Myocardial Infarction scheduled to undergo an early.
  • ELIXA STUDY Principal Investigator : A randomized, double blind, placebo group, multicenter study to evaluate cardiovascular outcomes during treatment with lixisenatide in type 2 diabetic patients after an Acute Coronary Syndrome
  • EPICOR ASIA Principal Investigator : Long term follow up of antithrombotic management patterns in acute coronary syndrome patients in Asia.
  • ODYSSEY STUDY: Principal Investigator
Doctors Timing: 
Sunday: Closed
Monday: 10:30-16:00
Tuesday: 10:30-14:00
Wednesday: 10:30-17:30
Thursday: 10:30-14:00
Friday: 10:30-16:00
Saturday: 10:30-17:30
OPD Instruction: 
M,Th (Appointments) N/A 2nd and 4th Thurs
Main Speciality: 

Other Cardiology Team Members